Medtronic Receives CE Mark For Its Next Generation Cardiac Resynchronization Therapy-Pacemakers Post author:Sam Post published:February 23, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Dynavax Secures $175 Million in Funding to Support Launch of Recently Approved Heplisav-B February 19, 2018 Bay Area Versartis's Stock Collapses as Growth Hormone Drug Flunks Phase III Test September 21, 2017 Another Drug Bites the Dust: Merck & Co. Stops Late-Stage Alzheimer???s Study February 14, 2017
Dynavax Secures $175 Million in Funding to Support Launch of Recently Approved Heplisav-B February 19, 2018